Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues

December 28, 2017 4:08 PM

Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.


Corporate News Earnings Guidance